A multi-center retrospective study evaluating effect of Crizotinib on the control of brain metastasis and survival outcomes among advanced ALK-rearranged NSCLC patients with brain metastasis in Chinese population
Latest Information Update: 02 May 2019
At a glance
- Drugs Crizotinib (Primary)
- Indications Brain metastases; Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 25 Apr 2019 Results published in the Targeted Oncology.
- 10 Oct 2018 New trial record
- 26 Sep 2018 Results presented at the 19th World Conference on Lung Cancer